Questions about a ‘simple blood test’ to screen for cancer prompt revealing answer: It’s complicated
A hyped news release gets revised at ASCO: Did it lead to improved coverage from journalists?
Are the clinical trial results for breast cancer drug taselisib ‘incredibly exciting’ or ‘disappointing’?
As world’s largest cancer conference gets underway, keep these three tweets in mind
ASCO pumps up a one-sided view of lung cancer screening: Here’s what most of the coverage missed
ASCO 2018: How a major medical meeting uses embargoes to shape the news, and what the consequences may be
CAR T-cell therapy — Why it’s too soon to speculate about a ‘cure’ for multiple myeloma
High drug costs (and stock values) take center stage at final day of ASCO
Small studies get big headlines at ASCO 2017
Readers drowning in flawed “liquid biopsy” stories; other coverage throws a lifeline